ECO Animal Health Group plc (EAH.L) Research

ECO Animal Health Group plc, established in 1972 and based in New Malden, United Kingdom, focuses on the worldwide research, regulatory approval, and distribution of veterinary pharmaceutical solutions. The company's offerings include Aivlosin, a macrolide antibiotic specifically formulated to address digestive and respiratory illnesses in pigs and poultry. Additionally, its product range encompasses various generic drugs like Ecomectin, Ecoheart, Ecotraz, and Ecomintic. These endectocides and other antiparasitics are designed to manage and prevent parasitic infestations such as worms, ticks, and lice across a diverse array of animals, including cattle, sheep, pigs, horses, and dogs. ECO Animal Health Group also provides Chlortetracycline and Oxytetracycline for treating bacterial infections in swine, fowl, and bovine animals.

Market snapshot

Symbol
EAH.L
Price
$89.00
Day change
0.00%
Market cap
$60.3M
P/E ratio
19.97x
52-week range
55.555-116.9
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 3 days

Peer companies

  • AOTI, Inc. (AOTI.L)
  • Creo Medical Limited (CREO.L)
  • Hemogenyx Pharmaceuticals Plc (HEMO.L)
  • hVIVO plc (HVO.L)
  • ImmuPharma plc (IMM.L)
  • Kooth plc (KOO.L)
  • Ondine Biomedical Inc. (OBI.L)
  • INSPECS Group plc (SPEC.L)

Open ECO Animal Health Group plc (EAH.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.